US5744327A
(en)
*
|
1990-02-20 |
1998-04-28 |
Board Of Regents, The University Of Texas System |
Methods for producing insulin in response to non-glucose secretagogues
|
US5427940A
(en)
*
|
1991-06-03 |
1995-06-27 |
Board Of Regents, The University Of Texas System |
Engineered cells producing insulin in response to glucose
|
US5792656A
(en)
*
|
1991-06-03 |
1998-08-11 |
Board Of Regents, The University Of Texas System |
Methods of preparing genetically engineered cells that produce insulin in response to glucose
|
US5571787A
(en)
|
1993-07-30 |
1996-11-05 |
Myelos Corporation |
Prosaposin as a neurotrophic factor
|
CA2169292C
(en)
*
|
1993-08-12 |
2010-11-23 |
E. Edward Baetge |
Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
US5908623A
(en)
*
|
1993-08-12 |
1999-06-01 |
Cytotherapeutics, Inc. |
Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
US5550050A
(en)
|
1994-04-15 |
1996-08-27 |
Cytotherapeutics, Inc. |
Method for implanting encapsulated cells in a host
|
US5670347A
(en)
|
1994-05-11 |
1997-09-23 |
Amba Biosciences Llc |
Peptide-mediated gene transfer
|
US5776747A
(en)
*
|
1994-07-20 |
1998-07-07 |
Cytotherapeutics, Inc. |
Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer
|
US6444201B1
(en)
*
|
1995-05-12 |
2002-09-03 |
The Rockefeller University |
Treatment of alzheimer disease by modulation of synapsins
|
IN181898B
(da)
*
|
1995-06-07 |
1998-10-24 |
Cytotherapeutics Inc |
|
US7364894B2
(en)
*
|
1995-09-15 |
2008-04-29 |
Centelion |
Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
|
FR2738842B1
(fr)
*
|
1995-09-15 |
1997-10-31 |
Rhone Poulenc Rorer Sa |
Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique
|
US7279313B2
(en)
*
|
1995-09-15 |
2007-10-09 |
Centelion |
Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
|
US5731284A
(en)
*
|
1995-09-28 |
1998-03-24 |
Amgen Inc. |
Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
|
WO1997012635A1
(en)
*
|
1995-10-02 |
1997-04-10 |
Cytotherapeutics, Inc. |
Method for treating amyotrophic lateral sclerosis
|
US5855613A
(en)
*
|
1995-10-13 |
1999-01-05 |
Islet Sheet Medical, Inc. |
Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
|
US5929041A
(en)
*
|
1996-02-23 |
1999-07-27 |
Amgen Inc. |
Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product
|
US5837681A
(en)
*
|
1996-02-23 |
1998-11-17 |
Amgen Inc. |
Method for treating sensorineural hearing loss using glial cell line-derived neurotrophic factor (GDNF) protein product
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
US7297331B2
(en)
*
|
1996-04-03 |
2007-11-20 |
The Rogosin Institute |
Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
|
US6224912B1
(en)
|
1996-04-03 |
2001-05-01 |
The Rogo Institute |
Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
|
US6210664B1
(en)
*
|
1996-04-08 |
2001-04-03 |
New York University Medical Center |
Method for gene transfer to the central nervous system
|
AU2674097A
(en)
*
|
1996-04-17 |
1997-11-07 |
Cytotherapeutics, Inc. |
Method and device for delivery of apoptosis-inducing molecules
|
US7138251B1
(en)
|
1996-04-22 |
2006-11-21 |
Amgen Inc. |
Polynucleotides encoding a neurotrophic factor receptor
|
US6027721A
(en)
*
|
1996-05-20 |
2000-02-22 |
Cytotherapeutics, Inc. |
Device and method for encapsulated gene therapy
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
US6054142A
(en)
*
|
1996-08-01 |
2000-04-25 |
Cyto Therapeutics, Inc. |
Biocompatible devices with foam scaffolds
|
US6150164A
(en)
*
|
1996-09-30 |
2000-11-21 |
The Regents Of The University Of Michigan |
Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
|
US6593290B1
(en)
|
1996-11-01 |
2003-07-15 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
US6156728A
(en)
|
1996-11-01 |
2000-12-05 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
US5952226A
(en)
*
|
1996-11-05 |
1999-09-14 |
Modex Therapeutiques |
Hypoxia responsive EPO producing cells
|
NZ336865A
(en)
|
1997-01-23 |
2001-01-26 |
Sumitomo Pharma |
Use of a therapeutic agent containing a neurotrophic factor for treatment of diabetes and hyperlipemia
|
US5844077A
(en)
*
|
1997-04-28 |
1998-12-01 |
Cytotherapeutics, Inc. |
Use of conantokins for producing analgesia or for neuroprotection
|
US6042579A
(en)
*
|
1997-04-30 |
2000-03-28 |
Medtronic, Inc. |
Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain
|
EP0983354A2
(en)
*
|
1997-05-30 |
2000-03-08 |
Amgen Inc. |
Neurotrophic factor receptors
|
US6254865B1
(en)
|
1997-06-17 |
2001-07-03 |
University Technology Corporation |
Method of treating huntington's disease using HNT neurons
|
US6167888B1
(en)
*
|
1997-06-30 |
2001-01-02 |
The Regents Of The University Of California |
Method for inducing partial recovery of lost voluntary motor function after spinal cord injury in a mammal
|
US6121415A
(en)
|
1997-07-09 |
2000-09-19 |
Genentech, Inc. |
ErbB4 receptor-specific neuregolin related ligands and uses therefor
|
ZA986077B
(en)
|
1997-07-09 |
2000-01-10 |
Genentech Inc |
ErbB4 receptor-specific neuregulin related ligands and uses therefor.
|
US6469311B1
(en)
|
1997-07-16 |
2002-10-22 |
Molecular Devices Corporation |
Detection device for light transmitted from a sensed volume
|
US6071748A
(en)
|
1997-07-16 |
2000-06-06 |
Ljl Biosystems, Inc. |
Light detection device
|
US6994856B1
(en)
|
1997-07-24 |
2006-02-07 |
Genentech, Inc. |
ErbB4 receptor-specific neuregulin related ligands and uses therefor
|
US6043221A
(en)
*
|
1997-07-30 |
2000-03-28 |
Amgen Inc. |
Method for preventing and treating hearing loss using a neuturin protein product
|
US6042909A
(en)
*
|
1997-09-03 |
2000-03-28 |
Circe Biomedical, Inc. |
Encapsulation device
|
US7745142B2
(en)
|
1997-09-15 |
2010-06-29 |
Molecular Devices Corporation |
Molecular modification assays
|
WO2000050877A1
(en)
|
1999-02-23 |
2000-08-31 |
Ljl Biosystems, Inc. |
Frequency-domain light detection device
|
US6825921B1
(en)
|
1999-11-10 |
2004-11-30 |
Molecular Devices Corporation |
Multi-mode light detection system
|
US6576476B1
(en)
|
1998-09-02 |
2003-06-10 |
Ljl Biosystems, Inc. |
Chemiluminescence detection method and device
|
US6297018B1
(en)
|
1998-04-17 |
2001-10-02 |
Ljl Biosystems, Inc. |
Methods and apparatus for detecting nucleic acid polymorphisms
|
US6326605B1
(en)
|
1998-02-20 |
2001-12-04 |
Ljl Biosystems, Inc. |
Broad range light detection system
|
US6156729A
(en)
*
|
1997-10-15 |
2000-12-05 |
California Institute Of Technology |
Leukemia inhibitory factor for use in modulating inflammation and pain
|
US6485901B1
(en)
*
|
1997-10-27 |
2002-11-26 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to linear beacons
|
CA2305787A1
(en)
|
2000-05-09 |
2001-11-09 |
The University Of British Columbia |
Cxcr4 antagonist treatment of hematopoietic cells
|
WO1999047158A2
(en)
|
1998-03-13 |
1999-09-23 |
The University Of British Columbia |
Therapeutic chemokine receptor antagonists
|
CA2245224A1
(en)
|
1998-08-14 |
2000-02-14 |
Jiang-Hong Giong |
Chemokine receptor antagonists and chemotherapeutics
|
US6277820B1
(en)
|
1998-04-09 |
2001-08-21 |
Genentech, Inc. |
Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells
|
US6303136B1
(en)
|
1998-04-13 |
2001-10-16 |
Neurotech S.A. |
Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
|
WO1999057248A1
(en)
*
|
1998-04-30 |
1999-11-11 |
President And Fellows Of Harvard College |
Induction of neuronal regeneration
|
US5973119A
(en)
*
|
1998-06-05 |
1999-10-26 |
Amgen Inc. |
Cyclin E genes and proteins
|
US6593133B1
(en)
|
1998-07-06 |
2003-07-15 |
Nsgene A/S |
Neurotrophic factors
|
WO2000004927A1
(en)
*
|
1998-07-24 |
2000-02-03 |
Alleghney University Of The Health Sciences |
Allogeneic cellular immunogens useful as cancer vaccines
|
AU5223899A
(en)
|
1998-07-27 |
2000-02-21 |
Ljl Biosystems, Inc. |
Apparatus and methods for spectroscopic measurements
|
AU5667599A
(en)
|
1998-07-27 |
2000-02-21 |
Ljl Biosystems, Inc. |
Apparatus and methods for time-resolved spectroscopic measurements
|
US20020115213A1
(en)
*
|
1998-08-14 |
2002-08-22 |
Northeastern Ohio Universities Of Medicine |
Engraftable neural progenitor & stem cells for brain tumor therapy
|
IL141865A0
(en)
*
|
1998-09-09 |
2002-03-10 |
Myelos Corp |
Method of stimulating prosaposin receptor activity
|
KR20010079770A
(ko)
*
|
1998-09-09 |
2001-08-22 |
추후제출 |
프로사포신 수용체 활성을 자극하는 방법
|
US6344541B1
(en)
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
US6156514A
(en)
*
|
1998-12-03 |
2000-12-05 |
Sunol Molecular Corporation |
Methods for making recombinant cells
|
US6303749B1
(en)
|
1999-01-29 |
2001-10-16 |
Amgen Inc. |
Agouti and agouti-related peptide analogs
|
US8624010B1
(en)
|
1999-02-03 |
2014-01-07 |
Steven K. Yoshinaga |
Nucleic acids encoding B7RP1
|
US7435796B1
(en)
|
1999-02-03 |
2008-10-14 |
Amgen Inc. |
Antibodies which bind B7RP1
|
US7708993B2
(en)
*
|
1999-02-03 |
2010-05-04 |
Amgen Inc. |
Polypeptides involved in immune response
|
SI2332976T1
(sl)
*
|
1999-02-03 |
2014-08-29 |
Amgen Inc. |
Novi polipeptidi, vkljuäśeni v imunskem odgovoru
|
US6713293B1
(en)
|
1999-02-08 |
2004-03-30 |
Friedrich Grummt |
Encapsulated cells containing an amplified expression vector as a drug delivery device
|
JP4812167B2
(ja)
*
|
1999-02-12 |
2011-11-09 |
モレキュラー インサイト ファーマスーティカルズ インコーポレイテッド |
薬物輸送用マトリックス、ならびにその作成方法および使用方法
|
US6903244B1
(en)
|
1999-02-26 |
2005-06-07 |
University Of Utah Research Foundation |
Mice which are +/− or −/− for the elastin gene as models for vascular disease
|
US6303355B1
(en)
|
1999-03-22 |
2001-10-16 |
Duke University |
Method of culturing, cryopreserving and encapsulating pancreatic islet cells
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6365385B1
(en)
|
1999-03-22 |
2002-04-02 |
Duke University |
Methods of culturing and encapsulating pancreatic islet cells
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
AU3770800A
(en)
|
1999-03-26 |
2000-10-16 |
Amgen, Inc. |
Beta secretase genes and polypeptides
|
US20070071734A1
(en)
*
|
1999-04-06 |
2007-03-29 |
Weng Tao |
ARPE-19 as platform cell line for encapsulated cell-based delivery
|
US6361771B1
(en)
|
1999-04-06 |
2002-03-26 |
Neurotech S.A. |
ARPE-19 as a platform cell line for encapsulated cell-based delivery
|
US6521431B1
(en)
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
US8147824B2
(en)
|
1999-08-05 |
2012-04-03 |
Athersys, Inc. |
Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
|
EP2348104A1
(en)
|
1999-08-05 |
2011-07-27 |
Mcl Llc |
Multipotent adult stem cells and methods for isolation
|
US7408047B1
(en)
|
1999-09-07 |
2008-08-05 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
US7459540B1
(en)
|
1999-09-07 |
2008-12-02 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
US6878543B1
(en)
|
1999-10-25 |
2005-04-12 |
Nsgene Sa |
Cultures of GFAP+ nestin+ cells that differentiate to neurons
|
US6267954B1
(en)
|
1999-11-24 |
2001-07-31 |
Universite De Paris V Rene-Descartes |
Intraocular transplantation of encapsulated cells
|
US7060676B2
(en)
*
|
1999-12-20 |
2006-06-13 |
Trustees Of Tufts College |
T. cruzi-derived neurotrophic agents and methods of use therefor
|
US6458118B1
(en)
|
2000-02-23 |
2002-10-01 |
Medtronic, Inc. |
Drug delivery through microencapsulation
|
US7514239B2
(en)
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
US7368425B2
(en)
|
2006-03-24 |
2008-05-06 |
Chemokine Therapeutics Corp. |
Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
|
US20050059584A1
(en)
|
2002-08-16 |
2005-03-17 |
Ahmed Merzouk |
Novel chemokine mimetics synthesis and their use
|
US7378098B2
(en)
|
2000-04-12 |
2008-05-27 |
The University Of British Columbia |
CXC chemokine receptor 4 agonist peptides
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
WO2002000724A2
(en)
|
2000-06-28 |
2002-01-03 |
Amgen, Inc. |
Thymic stromal lymphopoietin receptor molecules and uses thereof
|
MXPA02012718A
(es)
*
|
2000-06-28 |
2003-10-06 |
Amgen Inc |
Moleculas semejantes a b7 y sus usos.
|
US6538010B1
(en)
*
|
2000-11-08 |
2003-03-25 |
Research Triangle Institute |
Compounds and methods for promoting smoking cessation
|
JP4236925B2
(ja)
|
2000-11-28 |
2009-03-11 |
アムジエン・インコーポレーテツド |
免疫応答に関与する新規ポリペプチド
|
US7442370B2
(en)
|
2001-02-01 |
2008-10-28 |
Biogen Idec Ma Inc. |
Polymer conjugates of mutated neublastin
|
US7276580B2
(en)
|
2001-03-12 |
2007-10-02 |
Biogen Idec Ma Inc. |
Neurotrophic factors
|
EP1387670B1
(en)
*
|
2001-05-11 |
2008-10-15 |
Ortho-McNeil-Janssen Pharmaceuticals, Inc. |
Immune modulation device for use in animals
|
ES2339339T3
(es)
*
|
2001-06-22 |
2010-05-19 |
Universite Catholique De Louvain |
Perlas o capsulas de hidrogel como medios artificiales para la oviposicion de insectos y la cria de endoparasitoides.
|
EP1281767A3
(en)
*
|
2001-07-31 |
2003-05-28 |
Aladar A. Szalay |
Light emitting microorganisms and cells for diagnosis and therapy of tumors
|
US7332330B2
(en)
|
2001-09-11 |
2008-02-19 |
Renamed Biologics, Inc. |
Device for maintaining vascularization near an implant
|
US7981863B2
(en)
*
|
2001-09-19 |
2011-07-19 |
Neuronova Ab |
Treatment of Parkinson's disease with PDGF
|
DE10164039A1
(de)
*
|
2001-12-28 |
2003-07-10 |
Nmi Univ Tuebingen |
Implantierbare Vorrichtung und deren Verwendung
|
US7662924B2
(en)
|
2002-02-22 |
2010-02-16 |
The Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
US7442546B2
(en)
*
|
2002-03-15 |
2008-10-28 |
The Regents Of The University Of Michigan |
Method of modulating inflammatory response
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
NZ537220A
(en)
|
2002-05-16 |
2008-06-30 |
Absorber Ab |
Method of isolating an endothelial cell and method of donor specific crossmatching
|
US20030228261A1
(en)
*
|
2002-06-05 |
2003-12-11 |
Aladar Szalay |
Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
|
EP1369491A1
(en)
*
|
2002-06-05 |
2003-12-10 |
Aladar A. Szalay |
Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
|
ATE492630T1
(de)
*
|
2002-06-18 |
2011-01-15 |
Eisai R&D Man Co Ltd |
Primäre kultivierte adipozyten zur gentherapie
|
US7369894B2
(en)
*
|
2002-09-06 |
2008-05-06 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves
|
US7328069B2
(en)
*
|
2002-09-06 |
2008-02-05 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves
|
US7427280B2
(en)
|
2002-09-06 |
2008-09-23 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by delivering drugs to various nerves or tissues
|
US7328068B2
(en)
*
|
2003-03-31 |
2008-02-05 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudendal and associated nerves, and the optional delivery of drugs in association therewith
|
US7276057B2
(en)
*
|
2002-09-06 |
2007-10-02 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by drug delivery to the pudendal and sacral nerves
|
US7829694B2
(en)
|
2002-11-26 |
2010-11-09 |
Medtronic, Inc. |
Treatment of neurodegenerative disease through intracranial delivery of siRNA
|
US7605249B2
(en)
*
|
2002-11-26 |
2009-10-20 |
Medtronic, Inc. |
Treatment of neurodegenerative disease through intracranial delivery of siRNA
|
US7618948B2
(en)
*
|
2002-11-26 |
2009-11-17 |
Medtronic, Inc. |
Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
|
AU2002952993A0
(en)
|
2002-11-29 |
2002-12-12 |
The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland |
Therapeutic and diagnostic agents
|
US20040230182A1
(en)
*
|
2002-12-27 |
2004-11-18 |
Medtronic, Inc. |
Drug delivery through encapsulation
|
US7994149B2
(en)
|
2003-02-03 |
2011-08-09 |
Medtronic, Inc. |
Method for treatment of Huntington's disease through intracranial delivery of sirna
|
US7732591B2
(en)
*
|
2003-11-25 |
2010-06-08 |
Medtronic, Inc. |
Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna
|
ATE433759T1
(de)
|
2003-04-18 |
2009-07-15 |
Biogen Idec Inc |
Polymerkonjugiertes glycosiliertes neublastin
|
US7459152B2
(en)
*
|
2003-04-23 |
2008-12-02 |
Rush University Medical Center |
Erythropoietin administration to improve graft survival
|
EP1624936B1
(en)
|
2003-05-16 |
2009-10-28 |
Universite Laval |
Cns chloride modulation and uses thereof
|
ATE423134T1
(de)
|
2003-06-10 |
2009-03-15 |
Nsgene As |
Verbesserte sezernierung von neublastin
|
EP1644492B1
(en)
|
2003-06-18 |
2009-01-07 |
Genelux Corporation |
Modified recombinant vaccinia viruses, uses thereof
|
EP1667516A4
(en)
|
2003-08-29 |
2009-11-11 |
Inst Medical W & E Hall |
METHOD FOR SELECTION OF ANIMAL MODELS FROM ANIMALS MUTAGENICALLY SUBJECTED AND THE USE OF MYB TRANSCRIPTION FACTORS FOR SCREENING
|
DE602004025959D1
(de)
|
2003-10-20 |
2010-04-22 |
Nsgene As |
Viraler Vektor zur Verwendung in der in-vivo-Gentherapie von Morbus Parkinson
|
CA2551189A1
(en)
|
2003-12-24 |
2005-07-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Therapeutic agents and uses therefor
|
ATE409741T1
(de)
*
|
2004-01-19 |
2008-10-15 |
Nsgene As |
Nervenwachstumsfaktor sezernierende menschliche therapeutische zellen
|
US8467875B2
(en)
|
2004-02-12 |
2013-06-18 |
Medtronic, Inc. |
Stimulation of dorsal genital nerves to treat urologic dysfunctions
|
US20050208090A1
(en)
*
|
2004-03-18 |
2005-09-22 |
Medtronic, Inc. |
Methods and systems for treatment of neurological diseases of the central nervous system
|
EP2289911A3
(en)
|
2004-03-30 |
2011-03-30 |
NsGene A/S |
Therapeutic use of a growth factor, NsG33
|
CA2566549C
(en)
|
2004-05-12 |
2014-01-14 |
The Walter And Eliza Hall Institute Of Medical Research |
A method for isolating mammary stem cells
|
WO2005112959A2
(en)
|
2004-05-17 |
2005-12-01 |
Regents Of The University Of Minnesota |
Use of umbilical cord blood stem cells to treat ischemic event
|
US20090136552A1
(en)
*
|
2004-07-30 |
2009-05-28 |
Mette Gronborg |
Growth factors nsg28, nsg30, and nsg32
|
JP4959566B2
(ja)
|
2004-08-19 |
2012-06-27 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
トランスホーミング増殖因子βファミリータンパク質の折りたたみ
|
CA2577755C
(en)
|
2004-08-19 |
2014-05-13 |
Biogen Idec Ma Inc. |
Neublastin variants
|
US20060099193A1
(en)
*
|
2004-10-22 |
2006-05-11 |
Ikuko Sugaya |
Methods and materials for suppressing pain
|
AU2006228873B2
(en)
|
2005-04-01 |
2011-08-18 |
Nsgene A/S |
A human immortalised neural precursor cell line
|
US20060253068A1
(en)
*
|
2005-04-20 |
2006-11-09 |
Van Bilsen Paul |
Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart
|
WO2006118547A1
(en)
|
2005-04-29 |
2006-11-09 |
Agency For Science, Technology And Research |
Hyperbranched polymers and their applications
|
US20060257368A1
(en)
*
|
2005-05-03 |
2006-11-16 |
Clemson University |
Devices and methods for improved viability of cells
|
WO2006116789A2
(en)
|
2005-05-03 |
2006-11-09 |
Veterinärmedizinische Universität Wien |
Permeable capsules
|
EP1885854B1
(en)
*
|
2005-05-06 |
2012-10-17 |
Medtronic, Inc. |
Methods and sequences to suppress primate huntington gene expression
|
US7902352B2
(en)
*
|
2005-05-06 |
2011-03-08 |
Medtronic, Inc. |
Isolated nucleic acid duplex for reducing huntington gene expression
|
EP1883446B8
(en)
|
2005-05-17 |
2017-11-15 |
Gloria Therapeutics Sarl |
An implantable therapy system for treating a living being with an active factor
|
US20090169523A1
(en)
|
2005-06-13 |
2009-07-02 |
Catherine Verfaillie |
Hsc self-renewal
|
DK2407484T3
(da)
|
2005-06-24 |
2016-09-05 |
The Walter And Eliza Hall Inst Of Medical Res |
Terapeutisk pro-apoptotisk BH3-lignende molekyler og fremgangsmåder til at generere og/eller udvælge disse
|
US9133517B2
(en)
*
|
2005-06-28 |
2015-09-15 |
Medtronics, Inc. |
Methods and sequences to preferentially suppress expression of mutated huntingtin
|
US20080280843A1
(en)
*
|
2006-05-24 |
2008-11-13 |
Van Bilsen Paul |
Methods and kits for linking polymorphic sequences to expanded repeat mutations
|
US8357666B2
(en)
|
2005-08-01 |
2013-01-22 |
Nupotential, Inc. |
Reprogramming a cell by inducing a pluripotent gene through RNA interference
|
JP5164167B2
(ja)
|
2005-08-30 |
2013-03-13 |
ユニバーシティー オブ マイアミ |
免疫調節性腫瘍壊死因子受容体25(tnfr25)のアゴニスト、アンタゴニスト及び免疫毒素
|
US9388382B2
(en)
*
|
2005-10-05 |
2016-07-12 |
The Board Of Trustees Of The University Of Illinois |
Isolation of CD14 negative, CD45 positive and CD117 positive embryonic-like stem cells free of monocytes from human umbilical cord blood mononuclear cells
|
WO2007048413A1
(en)
*
|
2005-10-28 |
2007-05-03 |
Nsgene A/S |
IMPLANTABLE BIOCOMPATIBLE IMMtTNOISOLATORY VEHICLE FOR DELIVERY OF GDNF
|
US11000546B2
(en)
|
2005-11-09 |
2021-05-11 |
Athersys, Inc. |
Immunomodulatory properties of MAPCs and uses thereof
|
US10117900B2
(en)
*
|
2005-11-09 |
2018-11-06 |
Athersys, Inc. |
MAPC treatment of brain injuries and diseases
|
CN101360826B
(zh)
|
2005-11-18 |
2014-04-30 |
格兰马克药品股份有限公司 |
抗α2整联蛋白抗体及它们的用途
|
JP5247468B2
(ja)
|
2005-12-30 |
2013-07-24 |
ニューロテック ユーエスエー, インコーポレイテッド |
生物活性分子の送達のための微粒子化デバイスおよびその使用方法
|
DK1981515T3
(da)
|
2006-01-23 |
2013-07-22 |
Athersys Inc |
MAPC behandling af hjerneskader og -sygdomme
|
EP2392339A1
(en)
|
2006-01-23 |
2011-12-07 |
Athersys, Inc. |
MAPC Therapeutics without adjunctive immunosuppressive treatment
|
TWI501774B
(zh)
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
神經性病症之治療
|
JP5630781B2
(ja)
|
2006-04-14 |
2014-11-26 |
アドバンスド セル テクノロジー、インコーポレイテッド |
血管コロニー形成細胞
|
US20070255333A1
(en)
*
|
2006-04-28 |
2007-11-01 |
Medtronic, Inc. |
Neuromodulation therapy for perineal or dorsal branch of pudendal nerve
|
US9273356B2
(en)
|
2006-05-24 |
2016-03-01 |
Medtronic, Inc. |
Methods and kits for linking polymorphic sequences to expanded repeat mutations
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
EP2051726B1
(en)
|
2006-07-18 |
2018-04-18 |
University of Utah Research Foundation |
Methods for treating pain and screening analgesic compounds
|
US20080039415A1
(en)
*
|
2006-08-11 |
2008-02-14 |
Gregory Robert Stewart |
Retrograde transport of sirna and therapeutic uses to treat neurologic disorders
|
CA2666789C
(en)
*
|
2006-10-18 |
2016-11-22 |
Yong Zhao |
Embryonic-like stem cells derived from adult human peripheral blood and methods of use
|
US9375440B2
(en)
*
|
2006-11-03 |
2016-06-28 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
US7819842B2
(en)
*
|
2006-11-21 |
2010-10-26 |
Medtronic, Inc. |
Chronically implantable guide tube for repeated intermittent delivery of materials or fluids to targeted tissue sites
|
US7988668B2
(en)
*
|
2006-11-21 |
2011-08-02 |
Medtronic, Inc. |
Microsyringe for pre-packaged delivery of pharmaceuticals
|
US20080171906A1
(en)
*
|
2007-01-16 |
2008-07-17 |
Everaerts Frank J L |
Tissue performance via hydrolysis and cross-linking
|
US8545834B2
(en)
*
|
2007-03-15 |
2013-10-01 |
The Mclean Hospital Corporation |
G-substrate for the treatment and prevention of parkinson's disease
|
WO2008120107A2
(en)
|
2007-04-03 |
2008-10-09 |
Oxyrane (Uk) Limited |
Glycosylation of molecules
|
US8329655B2
(en)
|
2007-05-01 |
2012-12-11 |
Biogen Idec Ma Inc. |
Methods for increasing vascularization
|
MX2010001993A
(es)
|
2007-08-23 |
2010-03-11 |
Intrexon Corp |
Metodos y composiciones para diagnosticar una enfermedad.
|
WO2009029508A1
(en)
*
|
2007-08-28 |
2009-03-05 |
Johnnie B. Byrd, Sr. Alzheimer's Center And Research Institute, Inc. |
Intracranial catheter and methods of use
|
EP2205249B1
(en)
|
2007-09-28 |
2018-11-07 |
Intrexon Corporation |
Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
|
CN101815786A
(zh)
|
2007-10-12 |
2010-08-25 |
弗·哈夫曼-拉罗切有限公司 |
来自多个核酸的蛋白质表达
|
AU2009205886B2
(en)
|
2008-01-18 |
2015-08-27 |
Katholieke Universiteit Leuven |
Stem cell aggregates and methods for making and using
|
US20090196854A1
(en)
*
|
2008-02-04 |
2009-08-06 |
Kytos Biosystems S.A. |
Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery
|
WO2009126250A2
(en)
|
2008-04-07 |
2009-10-15 |
Nupotential, Inc. |
Reprogramming a cell by inducing a pluripotent gene through rna interference
|
WO2009125332A1
(en)
*
|
2008-04-07 |
2009-10-15 |
Peter Bromley |
New and safe procedure for immunization against infectious diseases agents
|
KR101923290B1
(ko)
|
2008-05-06 |
2018-11-28 |
아스텔라스 인스티튜트 포 리제너러티브 메디슨 |
혈관 콜로니 형성 세포 및 비-생착성 혈관 세포
|
JP5748654B2
(ja)
|
2008-05-06 |
2015-07-15 |
オカタ セラピューティクス, インコーポレイテッド |
多能性幹細胞に由来する除核赤血球細胞を産生するための方法
|
WO2009140649A2
(en)
*
|
2008-05-16 |
2009-11-19 |
Mclean Hosptial |
Rab3b for the treatment and prevention of parkinson's disease
|
JOP20190083A1
(ar)
|
2008-06-04 |
2017-06-16 |
Amgen Inc |
بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
|
CA2730710C
(en)
|
2008-07-24 |
2021-06-08 |
Nsgene A/S |
Therapeutic use of a growth factor, metrnl
|
US9446168B2
(en)
|
2010-06-07 |
2016-09-20 |
Beta-O2 Technologies Ltd. |
Multiple-layer immune barrier for donor cells
|
US9540630B2
(en)
*
|
2008-09-17 |
2017-01-10 |
Beta O2 Technologies Ltd. |
Optimization of alginate encapsulation of islets for transplantation
|
EA032727B1
(ru)
|
2008-10-10 |
2019-07-31 |
Амген Инк. |
Мутантный резистентный к протеолизу полипептид fgf21 и его применение
|
US20100158878A1
(en)
|
2008-12-23 |
2010-06-24 |
Alexandra Capela |
Target populations of oligodendrocyte precursor cells and methods of making and using same
|
JP5897335B2
(ja)
*
|
2009-01-23 |
2016-03-30 |
エヌエスジーン・アクティーゼルスカブNsGene A/S |
改良された細胞株及びカプセル化細胞生体送達におけるその使用
|
US20120021039A1
(en)
|
2009-01-23 |
2012-01-26 |
Nsgene A/S |
Expression of neuropeptides in mammalian cells
|
WO2010111278A1
(en)
|
2009-03-23 |
2010-09-30 |
The Texas A&M University System |
Compositions of mesenchymal stem cells to regenerate bone
|
US20150024024A1
(en)
*
|
2009-04-23 |
2015-01-22 |
Neurotech Usa, Inc. |
Cell Lines That Produce Prostaglandin F2 Alpha (PGF2A) And Uses Thereof
|
HRP20240135T1
(hr)
|
2009-05-05 |
2024-04-12 |
Amgen Inc. |
Fgf21 mutanti i njihove upotrebe
|
US20120052069A1
(en)
|
2009-05-05 |
2012-03-01 |
Amgen Inc |
Fgf21 mutants and uses thereof
|
BRPI0902039B8
(pt)
|
2009-06-09 |
2021-05-25 |
Anhanguera Educacional Ltda |
composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais
|
CA2806840C
(en)
|
2009-08-03 |
2019-08-27 |
Eckhard R. Podack |
Method for in vivo expansion of t regulatory cells
|
WO2011039634A2
(en)
|
2009-09-29 |
2011-04-07 |
Universiteit Gent |
Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose
|
CA2776748A1
(en)
*
|
2009-10-08 |
2011-04-14 |
Neurotech Usa, Inc. |
Use of pedf in an encapsulated cell-based delivery system
|
EP2501805B1
(en)
|
2009-11-19 |
2019-02-20 |
Oxyrane UK Limited |
Yeast strains producing mammalian-like complex n-glycans
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
US20110238036A1
(en)
*
|
2009-12-23 |
2011-09-29 |
Psivida Us, Inc. |
Sustained release delivery devices
|
ES2703428T3
(es)
|
2010-02-25 |
2019-03-08 |
Abt Holding Co |
Modulación de la angiogénesis
|
SG10201907877YA
(en)
|
2010-02-25 |
2019-09-27 |
Abt Holding Co |
Modulation of macrophage activation
|
AU2011239689A1
(en)
|
2010-04-15 |
2012-11-08 |
Amgen Inc. |
Human FGF receptor and beta-Klotho binding proteins
|
JP5988961B2
(ja)
|
2010-04-28 |
2016-09-07 |
ザ ジェイ. デヴィッド グラッドストーン インスティテューツ |
心筋細胞を発生させるための方法
|
SG10201503700WA
(en)
|
2010-05-12 |
2015-06-29 |
Abt Holding Co |
Modulation of splenocytes in cell therapy
|
ES2685171T3
(es)
|
2010-06-14 |
2018-10-05 |
The Scripps Research Institute |
Reprogramación de células a un nuevo destino
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
US9475709B2
(en)
|
2010-08-25 |
2016-10-25 |
Lockheed Martin Corporation |
Perforated graphene deionization or desalination
|
CA2812870C
(en)
|
2010-09-29 |
2020-06-09 |
Oxyrane Uk Limited |
Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
|
BR112013007263A2
(pt)
|
2010-09-29 |
2016-06-14 |
Oxyrane Uk Ltd |
desmanosilação de n-glicanos fosforilados
|
CN103269708A
(zh)
|
2010-10-01 |
2013-08-28 |
Ns基因公司 |
镍纹蛋白用于治疗异常性疼痛、痛觉过敏、自发性疼痛和幻痛的用途
|
US8815942B2
(en)
|
2010-10-20 |
2014-08-26 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease
|
AU2011336470B8
(en)
|
2010-12-01 |
2017-09-14 |
Alderbio Holdings Llc |
Anti-NGF compositions and use thereof
|
US9539324B2
(en)
|
2010-12-01 |
2017-01-10 |
Alderbio Holdings, Llc |
Methods of preventing inflammation and treating pain using anti-NGF compositions
|
US11214610B2
(en)
|
2010-12-01 |
2022-01-04 |
H. Lundbeck A/S |
High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
|
US9884909B2
(en)
|
2010-12-01 |
2018-02-06 |
Alderbio Holdings Llc |
Anti-NGF compositions and use thereof
|
US9078878B2
(en)
|
2010-12-01 |
2015-07-14 |
Alderbio Holdings Llc |
Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
|
US9067988B2
(en)
|
2010-12-01 |
2015-06-30 |
Alderbio Holdings Llc |
Methods of preventing or treating pain using anti-NGF antibodies
|
US9149427B2
(en)
|
2010-12-02 |
2015-10-06 |
Neurotech Usa, Inc. |
Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
|
CN114262690A
(zh)
|
2011-04-15 |
2022-04-01 |
吉恩勒克斯公司 |
减毒的痘苗病毒的克隆毒株及其使用方法
|
TWI535455B
(zh)
|
2011-06-06 |
2016-06-01 |
奇尼塔一有限責任公司 |
以shk為主之醫藥組合物及其製備方法及用途
|
US9474786B2
(en)
|
2011-09-05 |
2016-10-25 |
Nsgene A/S |
Treatment of allodynia
|
EP3628326B1
(en)
|
2012-03-15 |
2024-02-28 |
Oxyrane UK Limited |
Methods and materials for treatment of pompe's disease
|
US9610546B2
(en)
|
2014-03-12 |
2017-04-04 |
Lockheed Martin Corporation |
Separation membranes formed from perforated graphene and methods for use thereof
|
US10376845B2
(en)
|
2016-04-14 |
2019-08-13 |
Lockheed Martin Corporation |
Membranes with tunable selectivity
|
US10980919B2
(en)
|
2016-04-14 |
2021-04-20 |
Lockheed Martin Corporation |
Methods for in vivo and in vitro use of graphene and other two-dimensional materials
|
US9744617B2
(en)
|
2014-01-31 |
2017-08-29 |
Lockheed Martin Corporation |
Methods for perforating multi-layer graphene through ion bombardment
|
US10653824B2
(en)
|
2012-05-25 |
2020-05-19 |
Lockheed Martin Corporation |
Two-dimensional materials and uses thereof
|
US9834809B2
(en)
|
2014-02-28 |
2017-12-05 |
Lockheed Martin Corporation |
Syringe for obtaining nano-sized materials for selective assays and related methods of use
|
JP2015519370A
(ja)
|
2012-05-30 |
2015-07-09 |
ニューロテック ユーエスエー, インコーポレイテッド |
低温保存される植込み型細胞培養デバイスおよびその使用
|
CA2880808C
(en)
|
2012-08-01 |
2023-01-24 |
United Therapeutics Corporation |
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
|
CA2880811C
(en)
|
2012-08-01 |
2021-12-07 |
United Therapeutics Corporation |
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
|
EP3415150B1
(en)
|
2013-01-09 |
2021-08-18 |
United Therapeutics Corporation |
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
|
KR20150136047A
(ko)
|
2013-01-09 |
2015-12-04 |
유니버시티 오브 마이애미 |
TL1A-Ig 융합 단백질을 사용한 T 조절 세포의 조절을 위한 조성물 및 방법
|
WO2014136065A2
(en)
|
2013-03-05 |
2014-09-12 |
Oxyrane Uk Limited |
Production of catalytically active type i sulfatase
|
USD720469S1
(en)
|
2013-03-07 |
2014-12-30 |
Viacyte, Inc. |
Cell encapsulation device
|
JP6234485B2
(ja)
|
2013-03-07 |
2017-11-22 |
ヴィアサイト インコーポレイテッド |
3次元大収容力細胞封入デバイスアセンブリー
|
TW201504140A
(zh)
|
2013-03-12 |
2015-02-01 |
Lockheed Corp |
形成具有均勻孔尺寸之多孔石墨烯之方法
|
US9458246B2
(en)
|
2013-03-13 |
2016-10-04 |
Amgen Inc. |
Proteins specific for BAFF and B7RP1
|
JOP20140087B1
(ar)
|
2013-03-13 |
2021-08-17 |
Amgen Inc |
بروتينات مخصصة ل baff و b7rp1 وإستخداماتها
|
AU2014250761B2
(en)
|
2013-04-12 |
2019-02-28 |
Robert J. Deans |
Improving organs for transplantation
|
DK2992088T3
(da)
|
2013-04-30 |
2019-11-11 |
Univ Leuven Kath |
Celleterapi for myelodysplastiske syndromer
|
CA2913993A1
(en)
|
2013-05-31 |
2014-12-04 |
University Of Utah Research Foundation |
Conotoxin peptides, pharmaceutical compositions and uses thereof
|
US9572918B2
(en)
|
2013-06-21 |
2017-02-21 |
Lockheed Martin Corporation |
Graphene-based filter for isolating a substance from blood
|
AU2014318846A1
(en)
|
2013-09-11 |
2016-03-10 |
Neurotech Usa, Inc. |
Encapsulated cell therapy cartridge
|
WO2015042580A1
(en)
|
2013-09-23 |
2015-03-26 |
Biogen Idec Ma Inc. |
Compositions and methods for treatment of neuropathic pain
|
CN105940479A
(zh)
|
2014-01-31 |
2016-09-14 |
洛克希德马丁公司 |
使用宽离子场穿孔二维材料
|
CA2938305A1
(en)
|
2014-01-31 |
2015-08-06 |
Lockheed Martin Corporation |
Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer
|
JP2017512129A
(ja)
|
2014-03-12 |
2017-05-18 |
ロッキード・マーチン・コーポレーション |
有孔グラフェンから形成された分離膜
|
EP3188823A4
(en)
|
2014-09-02 |
2018-04-25 |
Lockheed Martin Corporation |
Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same
|
WO2016036322A1
(en)
*
|
2014-09-04 |
2016-03-10 |
Kemijski inštitut |
Cell-based device for local treatment with therapeutic protein
|
ES2833457T3
(es)
|
2015-05-27 |
2021-06-15 |
Neurotech Usa Inc |
Uso de terapia con células encapsuladas para el tratamiento del glaucoma
|
AU2016303048A1
(en)
|
2015-08-05 |
2018-03-01 |
Lockheed Martin Corporation |
Perforatable sheets of graphene-based material
|
AU2016303049A1
(en)
|
2015-08-06 |
2018-03-01 |
Lockheed Martin Corporation |
Nanoparticle modification and perforation of graphene
|
ES2959601T3
(es)
|
2015-10-27 |
2024-02-27 |
Univ Queensland |
Un polipéptido EphA4 modificado
|
EP3443329A4
(en)
|
2016-04-14 |
2020-04-08 |
Lockheed Martin Corporation |
METHODS FOR PROVIDING IN SITU MONITORING AND CONTROL OF DEFECT TRAINING OR HEALING
|
EP3442786A4
(en)
|
2016-04-14 |
2020-03-18 |
Lockheed Martin Corporation |
TWO-DIMENSIONAL MEMBRANE STRUCTURES HAVING FLOW PASSAGES
|
CA3020686A1
(en)
|
2016-04-14 |
2017-10-19 |
Lockheed Martin Corporation |
Method for treating graphene sheets for large-scale transfer using free-float method
|
JP2019521055A
(ja)
|
2016-04-14 |
2019-07-25 |
ロッキード・マーチン・コーポレーション |
グラフェン欠陥の選択的界面緩和
|
US10183058B2
(en)
|
2016-06-17 |
2019-01-22 |
Nymox Corporation |
Method of preventing or reducing the progression of prostate cancer
|
AU2017300590A1
(en)
|
2016-07-18 |
2019-01-24 |
Eth Zurich |
B-cell-mimetic cells
|
EP3272877A1
(en)
|
2016-07-18 |
2018-01-24 |
ETH Zurich |
B-cell-mimetic cells
|
US10172910B2
(en)
|
2016-07-28 |
2019-01-08 |
Nymox Corporation |
Method of preventing or reducing the incidence of acute urinary retention
|
US10532081B2
(en)
|
2016-09-07 |
2020-01-14 |
Nymox Corporation |
Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
|
ES2927406T3
(es)
|
2016-10-24 |
2022-11-04 |
United Therapeutics Corp |
Potenciación de las propiedades inmunomoduladoras de las MSC mediante treprostinil
|
JP7088564B2
(ja)
|
2016-11-10 |
2022-06-21 |
ヴィアサイト,インコーポレイテッド |
細胞送達装置におけるpdx1膵臓内胚葉細胞及びその方法
|
SG11201908127WA
(en)
|
2017-03-10 |
2019-10-30 |
Hoffmann La Roche |
Method for producing multispecific antibodies
|
EP3658204A4
(en)
*
|
2017-07-24 |
2021-06-23 |
California Institute of Technology |
REMOVABLE, CHEMICALLY AMPLIFIED, LOW POWER ELECTRICAL BARRIER
|
EP3656851A1
(en)
|
2018-11-23 |
2020-05-27 |
Technische Universität Dresden |
Artificial hla-positive feeder cell lines for nk cells and uses thereof
|
WO2022011081A1
(en)
|
2020-07-09 |
2022-01-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cell lines that produce human retinoschisin proteins and uses thereof
|
US20230383261A1
(en)
|
2020-10-14 |
2023-11-30 |
Sana Biotechnology, Inc. |
Hepatocyte-like cells
|
IT202100006569A1
(it)
|
2021-03-18 |
2022-09-18 |
Hemera S R L |
Metodo per ottenere macrofagi rigenerativi educati dal tumore e loro uso nella medicina rigenerativa
|
WO2023081420A1
(en)
|
2021-11-05 |
2023-05-11 |
Abt Holding Company |
Culture-expanded canine progenitor cells and related methods
|
WO2023164171A2
(en)
|
2022-02-25 |
2023-08-31 |
Viacyte, Inc. |
Multilayer implantable cell encapsulation devices and methods thereof
|